Literature DB >> 34125417

Blister-Packing of 2 mg Buprenorphine Monoproduct as a Patient-Centered Method of Microdosing for Buprenorphine Induction.

Anthony J Accurso1.   

Abstract

Entities:  

Year:  2021        PMID： 34125417     DOI： 10.1007/s40261-021-01048-z

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN： 1173-2563            Impact factor:   2.859


× No keyword cloud information.
  2 in total

1.  Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: protocol for an open-label, parallel-group, superiority, randomized controlled trial.

Authors:  Nickie Mathew; Pouya Azar; James S H Wong; Mohammadali Nikoo; Jean N Westenberg; Janet G Suen; Jennifer Y C Wong; Reinhard M Krausz; Christian G Schütz; Marc Vogel; Jesse A Sidhu; Jessica Moe; Shane Arishenkoff; Donald Griesdale
Journal:  Addict Sci Clin Pract       Date:  2021-02-12

Review 2.  The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder.

Authors:  Joao P De Aquino; Suprit Parida; Mehmet Sofuoglu
Journal:  Clin Drug Investig       Date:  2021-04-05       Impact factor: 2.859
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.